Latin America Protein Chip Market Overview
The Latin America Protein Chip Market size was estimated at US$168.41 million in 2025 and is forecast to reach US$888.93 million by 2035, growing at a CAGR of 18.1% during the forecast period 2026-2035.
Protein microarrays, also known as protein chips, are high-density parallel assay systems containing small amounts of proteins. Protein chips play an important function in diagnostics. With the help of these chips, healthcare providers can check the level of infection for a particular disease or disorder.
Protein chips have been extensively employed in healthcare and biological industries to conduct fundamental research. Furthermore, these chips have been used in drug development research initiatives including contagious and lethal disorders. Protein chips are made comprised of a support surface, such as a glass slide or microtitre plate, that aids in the capture of protein in use, and these molecules are then labelled and assembled in a dye of a certain colour and added to the array. Any interaction between them is then signalled and recorded for future experimentation.
Latin America Protein Chip Market Scope
| Metrics | Details |
| CAGR | 18.1% |
| Size Available for Years | 2025-2035 |
| Forecast Period | 2026-2035 |
| Data Availability | Value (US$) |
| Segments Covered | Technology, Application, and End User |
| Countries Covered | Brazil, Argentina, Chile, Mexico and Rest of Latin America |
| Largest Country | Brazil |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Market Drivers
Protein chips are being adopted at a rapid rate in the field of biomedical and biotechnology due to factors such as an increase in the percentage of geriatric people in Latin America, the prevalence of target diseases, rapid research and development in protein arrays, the study of protein interactions, and the growing demand for early detection of cancer. Furthermore, the emergence of many novel applications includes medical uses, protein chips such as DNA microarrays, protein-small molecule interactions, and the desire for individualized medications.
The demand for protein chips rose during the health crisis caused by the unique COVID-19 pandemic in 2020-2022 owing to their capacity to detect hazardous biological substances and provide quick diagnosis of many ailments. The finding of markers and medicines is a typical use of proteomics. Moreover, factors such as growing usage in cancer detection and treatment, as well as fast technology breakthroughs like sequence engineering, genome studies, and others, have a significant impact on the market.
Latin America Protein Chip Market Segmentation
The Latin America Protein Chip Market is segmented based on technology, application, and end user.
By Technology, the analytical microarrays segment is estimated to provide the bulk of revenue over the forecast period. Due to the multiple benefits offered, analytical microarrays are widely used in a range of applications, such as assessing a complex combination of proteins to find specificities, binding affinities, and levels of protein expression. In this method, a range of antibodies, aptamers, or affibodies are placed on a glass microscope slide, and the targeted protein is recognized in a sandwich assay format utilizing direct labelling or a reporter antibody.
Geographical Analysis
Geographically, Brazil is expected to have the greatest CAGR in revenue over the projected period, owing to rising demand for microarray testing and the region's sizable elderly population. Strict rules controlling the pharmaceutical and allied sectors in numerous developed nations, as well as the efficacy of quality control and quality assurance procedures, are also driving the regional market. As a consequence, this area has stayed at the forefront of growth potential and innovations in the field of protein chips throughout the years.
Mexico is expected to account for a substantial portion of revenue in the next years, owing to the existence of various pharmaceutical and bio-science firms, skilled labour, and several notable participants in the area of protein chips. Furthermore, the fast development of protein chips and the low cost of tests are expected to boost market growth.
Competitive Landscape
The major players in the Latin America Protein Chip Market are SEQUENOM, Inc., Sigma Aldrich Corporation, Affymetrix, Inc., EMD Millipore, Illumina, Inc., Life Technologies Corporation, and Agilent Technologies.
Key Developments
- Brazil expands access to multi-omics infrastructure: CNPEM's Brazilian Biorenewables National Laboratory introduced a new 2026 access model for its Multi-omics facility, with two annual proposal windows supporting advanced metagenomics, metatranscriptomics and metabolomics research. This can strengthen the regional infrastructure surrounding protein-analysis workflows.
- Open proteomics facilities support Latin American researchers: CNPEM's Brazilian Biosciences National Laboratory opened access to facilities covering mass spectrometry, protein purification, protein crystallization, bioassays and related life-science technologies, with financial support available to eligible researchers from Latin American and Caribbean countries.
- Brazil strengthens proteomics training: CNPEM scheduled its XV Proteomics Workshop for November 10–12, 2026, targeting researchers and professionals in biotechnology, structural biology, health sciences and related fields while expanding participation from Brazilian and international groups.
- Mexico advances its proteomics ecosystem: A 2026 review highlighted two decades of development by the Mexican Proteomics Society, including training, workshops, international collaboration and integration of Mexican researchers into global proteomics projects.
- Cancer proteomics research expands in Mexico: UNAM researchers reported 2026 work involving differential proteomic profiling of premalignant cervical lesions and cervical cancer, illustrating continued application of advanced protein-analysis methods to disease research.
- Argentina upgrades protein-analysis capabilities: CONICET's Mass Spectrometry Unit at the Institute of Molecular and Cellular Biology of Rosario added advanced technology in 2026 to improve characterization of monoclonal antibodies used in cancer therapies, strengthening high-precision protein analysis.
- Aptamer-based diagnostics emerge in Argentina: CONICET researchers announced progress on a rapid, low-cost dengue diagnostic using aptamers designed to recognize specific molecular targets, highlighting growing interest in affinity-based biomarker detection technologies.
- Argentina expands genomic technology collaboration: ANLIS Malbrán signed a 2026 collaboration agreement with Illumina to strengthen genomic surveillance, including validation of a panel capable of detecting close to 200 viruses. The development adds advanced molecular-analysis infrastructure relevant to the broader omics ecosystem.
